270 related articles for article (PubMed ID: 29703731)
1. Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain.
Stockstill K; Doyle TM; Yan X; Chen Z; Janes K; Little JW; Braden K; Lauro F; Giancotti LA; Harada CM; Yadav R; Xiao WH; Lionberger JM; Neumann WL; Bennett GJ; Weng HR; Spiegel S; Salvemini D
J Exp Med; 2018 May; 215(5):1301-1313. PubMed ID: 29703731
[TBL] [Abstract][Full Text] [Related]
2. The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1.
Janes K; Little JW; Li C; Bryant L; Chen C; Chen Z; Kamocki K; Doyle T; Snider A; Esposito E; Cuzzocrea S; Bieberich E; Obeid L; Petrache I; Nicol G; Neumann WL; Salvemini D
J Biol Chem; 2014 Jul; 289(30):21082-97. PubMed ID: 24876379
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain.
Chen Z; Doyle TM; Luongo L; Largent-Milnes TM; Giancotti LA; Kolar G; Squillace S; Boccella S; Walker JK; Pendleton A; Spiegel S; Neumann WL; Vanderah TW; Salvemini D
Proc Natl Acad Sci U S A; 2019 May; 116(21):10557-10562. PubMed ID: 31068460
[TBL] [Abstract][Full Text] [Related]
4. Sexually dimorphic therapeutic response in bortezomib-induced neuropathic pain reveals altered pain physiology in female rodents.
Stockstill K; Wahlman C; Braden K; Chen Z; Yosten GL; Tosh DK; Jacobson KA; Doyle TM; Samson WK; Salvemini D
Pain; 2020 Jan; 161(1):177-184. PubMed ID: 31490328
[TBL] [Abstract][Full Text] [Related]
5. Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation.
Grenald SA; Doyle TM; Zhang H; Slosky LM; Chen Z; Largent-Milnes TM; Spiegel S; Vanderah TW; Salvemini D
Pain; 2017 Sep; 158(9):1733-1742. PubMed ID: 28570482
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine-1-phosphate signaling: A novel target for simultaneous adjuvant treatment of triple negative breast cancer and chemotherapy-induced neuropathic pain.
Singh SK; Spiegel S
Adv Biol Regul; 2020 Jan; 75():100670. PubMed ID: 31708456
[TBL] [Abstract][Full Text] [Related]
7. Differential Tolerance to FTY720-Induced Antinociception in Acute Thermal and Nerve Injury Mouse Pain Models: Role of Sphingosine-1-Phosphate Receptor Adaptation.
Sim-Selley LJ; Wilkerson JL; Burston JJ; Hauser KF; McLane V; Welch SP; Lichtman AH; Selley DE
J Pharmacol Exp Ther; 2018 Sep; 366(3):509-518. PubMed ID: 29945931
[TBL] [Abstract][Full Text] [Related]
8. Bortezomib induces neuropathic pain through protein kinase C-mediated activation of presynaptic NMDA receptors in the spinal cord.
Xie JD; Chen SR; Chen H; Pan HL
Neuropharmacology; 2017 Sep; 123():477-487. PubMed ID: 28663117
[TBL] [Abstract][Full Text] [Related]
9. Fingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in the dorsal horn.
Doolen S; Iannitti T; Donahue RR; Shaw BC; Grachen CM; Taylor BK
Pain; 2018 Feb; 159(2):224-238. PubMed ID: 29140922
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine 1-phosphate enhances the excitability of rat sensory neurons through activation of sphingosine 1-phosphate receptors 1 and/or 3.
Li C; Li JN; Kays J; Guerrero M; Nicol GD
J Neuroinflammation; 2015 Apr; 12():70. PubMed ID: 25880547
[TBL] [Abstract][Full Text] [Related]
11. Activation of Sphingosine-1-Phosphate Receptor 1 in the Spinal Cord Produces Mechanohypersensitivity Through the Activation of Inflammasome and IL-1β Pathway.
Doyle TM; Chen Z; Durante M; Salvemini D
J Pain; 2019 Aug; 20(8):956-964. PubMed ID: 30802544
[TBL] [Abstract][Full Text] [Related]
12. Gaining on Pain.
Emery EC; Wood JN
N Engl J Med; 2018 Aug; 379(5):485-487. PubMed ID: 30067934
[No Abstract] [Full Text] [Related]
13. Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination.
Kim S; Bielawski J; Yang H; Kong Y; Zhou B; Li J
Glia; 2018 Mar; 66(3):654-669. PubMed ID: 29193293
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine-1-phosphate receptor subtype 1 activation in the central nervous system contributes to morphine withdrawal in rodents.
Doyle TM; Hutchinson MR; Braden K; Janes K; Staikopoulos V; Chen Z; Neumann WL; Spiegel S; Salvemini D
J Neuroinflammation; 2020 Oct; 17(1):314. PubMed ID: 33092620
[TBL] [Abstract][Full Text] [Related]
15. Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers.
Cartwright TA; Campos CR; Cannon RE; Miller DS
J Cereb Blood Flow Metab; 2013 Mar; 33(3):381-8. PubMed ID: 23168528
[TBL] [Abstract][Full Text] [Related]
16. Blocking SphK/S1P/S1PR1 axis signaling pathway alleviates remifentanil-induced hyperalgesia in rats.
Li J; Wang Q; Gao Y; Ma W; Sun Z; Yu Y; Li Y; Li Q; Wang C
Neurosci Lett; 2023 Mar; 801():137131. PubMed ID: 36801239
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-phosphate receptor 1 activation in the central nervous system drives cisplatin-induced cognitive impairment.
Squillace S; Niehoff ML; Doyle TM; Green M; Esposito E; Cuzzocrea S; Arnatt CK; Spiegel S; Farr SA; Salvemini D
J Clin Invest; 2022 Sep; 132(17):. PubMed ID: 36047496
[TBL] [Abstract][Full Text] [Related]
18. S1PR1 (Sphingosine-1-Phosphate Receptor 1) Signaling Regulates Blood Flow and Pressure.
Cantalupo A; Gargiulo A; Dautaj E; Liu C; Zhang Y; Hla T; Di Lorenzo A
Hypertension; 2017 Aug; 70(2):426-434. PubMed ID: 28607130
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine 1-phosphate but not Fingolimod protects neurons against excitotoxic cell death by inducing neurotrophic gene expression in astrocytes.
Tran C; Heng B; Teo JD; Humphrey SJ; Qi Y; Couttas TA; Stefen H; Brettle M; Fath T; Guillemin GJ; Don AS
J Neurochem; 2020 Apr; 153(2):173-188. PubMed ID: 31742704
[TBL] [Abstract][Full Text] [Related]
20. Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain.
Cannon RE; Peart JC; Hawkins BT; Campos CR; Miller DS
Proc Natl Acad Sci U S A; 2012 Sep; 109(39):15930-5. PubMed ID: 22949658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
